There is no single age at which every older adult should stop taking statins. The answer depends almost entirely on why you’re taking them. If you’ve already had a heart attack or stroke, the evidence strongly favors continuing. If you’ve never had a cardiovascular event, the case for statins after age 75 becomes much less clear, and major guidelines acknowledge there simply isn’t enough data to make a firm recommendation either way.
Primary vs. Secondary Prevention: The Key Distinction
The most important factor isn’t age itself. It’s whether you’re taking a statin to prevent a first heart attack or stroke (primary prevention) or to prevent a second one (secondary prevention). These are fundamentally different situations with different evidence behind them.
For primary prevention in adults 76 and older, the U.S. Preventive Services Task Force issued an “I” statement, meaning the evidence is insufficient to recommend for or against starting a statin. The 2018 American Heart Association and American College of Cardiology guidelines don’t provide primary prevention recommendations for anyone over 75 either. Both organizations openly acknowledge there is too little data in this age group to make a strong, risk-based recommendation. Among major international guidelines, only the UK’s NICE guideline (from 2014) offers a clear recommendation, and that’s largely because its risk calculator automatically assigns everyone over 75 a high enough risk score to qualify.
For secondary prevention, the picture is very different. If you have known vascular disease, such as a prior heart attack, stroke, or blocked arteries, guidelines recommend continuing your statin regardless of age. A Swedish study of more than 14,900 heart attack patients over age 80 found that those discharged on a statin had a 37% reduction in cardiovascular death compared to those who weren’t prescribed one.
What Happens When You Stop
A large Danish cohort study published in JAMA Network Open tracked what happened when older adults on long-term statin therapy discontinued their medication. Among those with a history of cardiovascular disease, stopping statins was associated with 13 extra major cardiovascular events per 1,000 people per year compared to those who continued. Put another way, for every 77 people with prior heart disease who stopped their statin, one experienced an additional heart attack or stroke within a year.
The study also found a higher event rate among primary prevention patients who stopped, though the absolute difference was smaller. This suggests that even in people without prior cardiovascular events, abruptly stopping a long-term statin isn’t risk-free.
Muscle Pain and Side Effects in Older Adults
One of the most common reasons older adults want to stop statins is muscle pain, or myopathy. The concern is legitimate. In one study, about 34% of patients aged 60 to 79 reported muscle-related symptoms while on statins, compared to roughly 27% of those in their 40s. While the study didn’t find this age-related increase to be statistically significant, the trend is consistent with what doctors observe in practice: older bodies are more vulnerable to muscle side effects.
Older adults also face a higher risk of drug interactions. Statins are processed through the liver using the same pathways as many other commonly prescribed medications, and seniors tend to take more drugs overall. When multiple medications compete for the same processing pathway, statin levels in the blood can rise, increasing the chance of muscle damage or other adverse effects. This is one reason why a statin that worked fine at age 60 might start causing problems at 80, even at the same dose.
Frailty and Life Expectancy Matter More Than Age
Doctors increasingly look at frailty rather than a specific birthday when deciding whether to continue statins. A UK cohort study of people over 80 found that statin deprescribing (the clinical term for intentionally stopping a medication) increased as frailty worsened: about 5% of fit participants stopped their statin each year, compared to 7.1% of those with severe frailty. UK recommendations specifically advise that statin decisions in this age group should be based on patient preference, the number of other medications being taken, overall frailty, and estimated life expectancy.
This makes intuitive sense. Statins reduce risk over years, not days. If someone’s life expectancy is short due to advanced illness or severe frailty, the long-term benefit may never materialize, while the daily burden of another pill (and its potential side effects) is immediate. On the other hand, a healthy, active 82-year-old with well-controlled blood pressure and no side effects may have years of benefit ahead.
Statins and Cognitive Function
Many older adults worry that statins cause memory problems. The FDA added a warning about cognitive effects to statin labels in 2012, which understandably raised concern. However, the bulk of evidence points in the opposite direction. A large meta-analysis of 55 studies covering more than 7 million patients found that statin use was associated with a 14% lower risk of dementia overall and an 18% lower risk of Alzheimer’s disease specifically. The protective effect was strongest in people who took statins for more than three years, where the risk of dementia dropped by 63% compared to nonusers.
That said, the randomized controlled trials that specifically measured cognitive outcomes haven’t confirmed this benefit. The PROSPER trial, which focused on elderly participants, found no significant difference in cognitive decline between statin and placebo groups over several years. The same was true for two other major trials. So while statins don’t appear to harm cognition, the hoped-for protective effect hasn’t been proven in the most rigorous study designs.
What We’re Still Waiting to Learn
One reason guidelines remain vague about statins after 75 is that older adults have historically been underrepresented in clinical trials. The STAREE trial, which enrolled nearly 10,000 healthy adults aged 70 and older, is designed to answer this question directly. It’s comparing daily statin therapy to placebo and measuring not just cardiovascular events but disability-free survival, meaning years lived independently outside of nursing care. Results are expected by the end of 2025 and could significantly change recommendations for this age group.
How the Decision Gets Made in Practice
For now, the decision to continue or stop a statin in your 70s, 80s, or beyond typically comes down to a conversation with your doctor that weighs several factors together:
- History of heart disease or stroke: If you have one, continuing is almost always recommended.
- Diabetes: Guidelines suggest starting or continuing a statin for adults 75 to 84 with type 2 diabetes, even without prior cardiovascular events.
- Side effects: Persistent muscle pain, weakness, or drug interactions that can’t be resolved by switching to a different statin are valid reasons to stop.
- Frailty and life expectancy: The more frail you are, the less likely you are to benefit from a medication that works over years.
- Number of medications: If you’re taking many drugs, removing one that may have marginal benefit can reduce interaction risks and simplify your daily routine.
- Your preferences: How you feel about taking the medication, your tolerance for risk, and what matters most to you in terms of quality of life are all part of the equation.
If you and your doctor decide to stop, the evidence suggests it’s worth monitoring rather than simply walking away. The Danish study showed that cardiovascular risk rises after discontinuation even in primary prevention patients, so periodic check-ins on cholesterol levels and overall cardiovascular health remain important.